Home > Products > EGFR & MET
> Recombinant Anti-EGFR x Anti-MET Bispecific Antibody (Fv-IgG)
Recombinant Anti-EGFR x Anti-MET Bispecific Antibody (Fv-IgG) (CAT#: BSDG-154)
Recombinant Anti-EGFR x Anti-MET Bispecific Antibody (Fv-IgG) is an appended IgG format, which has 2+2 antigen-binding valency. This dual variable domain IgG is generated by appending variable domains of an anti-EGFR IgG with similar domains from an anti-MET antibody via short peptide linkers, or vice versa. This BsAb can bind and inactivate two receptors simultaneously. It is designed for the research of Colorectal cancer; Pancreatic cancer; Head and neck cancer; Non-small cell lung cancer (NSCLC) therapy.
There are currently no customer reviews or questions for Recombinant Anti-EGFR x Anti-MET Bispecific Antibody (Fv-IgG) (BSDG-154). Click the button below to contact us or submit your feedback about this product.